Ganglion impar block (GIB) is a commonly used interventional option for refractory chronic coccydynia. Caudal epidural steroid injection (CESI) targets the sacral and coccygeal roots and may theoretically augment the analgesic efficacy of GIB. Evidence comparing GIB alone with a combined GIB and CESI approach, however, remains limited. This study compared long‐term pain outcomes after GIB monotherapy versus GIB combined with CESI. In this retrospective single‐center study (Jan 2020–May 2025), we evaluated 56 adults with chronic coccydynia who underwent GIB alone (Group A) or in combination with CESI (Group B). Pain intensity was assessed using the 11‐point numeric rating scale (NRS‐11) at baseline and at 1 h, 1 month, and 6 months after the procedure. Multivariable logistic regression was used to explore predictors of 6‐month response, including early postprocedural pain change and sex. Significant improvements in pain intensity were observed in both groups and sustained over 6 months. Responder rates at 6 months were comparable between the GIB‐only (41.7%) and GIB with CESI (45.0%) groups (p > 0.05). Multivariable analysis revealed that greater early pain relief (baseline to 1 h) significantly predicted 6‐month favorable outcomes (OR: 2.08; 95% CI: 1.26–3.42; p = 0.004), whereas male sex was associated with significantly reduced odds of response (OR: 0.11; 95% CI: 0.02–0.72; p = 0.022). In this single‐center retrospective cohort, GIB was associated with sustained pain relief in a substantial proportion of patients with chronic coccydynia, while the addition of CESI did not confer a clear incremental benefit. Importantly, immediate postprocedural pain relief served as a robust predictor of long‐term success, whereas male sex was identified as a negative prognostic factor. Prospective, adequately powered randomized trials are needed to confirm these exploratory findings and to refine patient selection for GIB‐based interventions. Trial Registration: ClinicalTrials.gov Identifier: NCT07200765
Epidural catheters and epidural port systems are widely used in interventional pain management; however, infectious complications remain an important safety concern, particularly during prolonged catheterization. This retrospective real-world cohort study evaluated the incidence, microbiological characteristics, and time-dependent risk factors of epidural catheter- and port-related infections in a tertiary pain clinic. A total of 352 patients were included after predefined exclusion criteria were applied. Infection was defined based on clinical findings and microbiological confirmation. The overall infection rate was 10.5% (37/352). Catheter duration was significantly longer in patients who developed infection and remained an independent predictor in multivariable logistic regression analysis (odds ratio per day: 1.12; 95% CI: 1.06–1.19; p = 0.002). Receiver operating characteristic analysis demonstrated moderate discriminatory ability of catheter duration for predicting infection (AUC = 0.68), with an optimal cut-off of 7 days. The most frequently isolated pathogens were methicillin-resistant coagulase-negative staphylococci. No cases of meningitis or sepsis occurred, and all infections were successfully managed with antibiotic therapy. These findings emphasize the importance of duration-based risk assessment and careful follow-up strategies in patients requiring prolonged epidural analgesia.
Background: Ganglion impar block (GIB) is a commonly used interventional option for refractory chronic coccydynia. Caudal epidural steroid injection (CESI) targets the sacral and coccygeal roots and may theoretically augment the analgesic efficacy of GIB. Evidence comparing GIB alone with a combined GIB and CESI approach, however, remains limited. This study compared long‐term pain outcomes after GIB monotherapy versus GIB combined with CESI. Methods: In this retrospective single‐center study (Jan 2020–May 2025), we evaluated 56 adults with chronic coccydynia who underwent GIB alone (Group A) or in combination with CESI (Group B). Pain intensity was assessed using the 11‐point numeric rating scale (NRS‐11) at baseline and at 1 h, 1 month, and 6 months after the procedure. Multivariable logistic regression was used to explore predictors of 6‐month response, including early postprocedural pain change and sex. Results: Significant improvements in pain intensity were observed in both groups and sustained over 6 months. Responder rates at 6 months were comparable between the GIB‐only (41.7%) and GIB with CESI (45.0%) groups ( p > 0.05). Multivariable analysis revealed that greater early pain relief (baseline to 1 h) significantly predicted 6‐month favorable outcomes (OR: 2.08; 95% CI: 1.26–3.42; p = 0.004), whereas male sex was associated with significantly reduced odds of response (OR: 0.11; 95% CI: 0.02–0.72; p = 0.022). Conclusions: In this single‐center retrospective cohort, GIB was associated with sustained pain relief in a substantial proportion of patients with chronic coccydynia, while the addition of CESI did not confer a clear incremental benefit. Importantly, immediate postprocedural pain relief served as a robust predictor of long‐term success, whereas male sex was identified as a negative prognostic factor. Prospective, adequately powered randomized trials are needed to confirm these exploratory findings and to refine patient selection for GIB‐based interventions. Trial Registration: ClinicalTrials.gov Identifier: NCT07200765